Co-founder, Strategic Advisor at Oncko
Intro paths
→
In turn, Bill can intro founders to Oncko's investors below.
Oncko's investors · 3
Co-founders at Oncko
AD
Atray DixitCo-founder, CEO
Experience
- enGeneInterim CMOcurrent2026 — present
- enGeneMember Board of Directorscurrent2025 — present
- LTZ TherapeuticsInterim CMOcurrent2026 — present
- LTZ TherapeuticsMember of the Board of Advisorscurrent2025 — present
- Grossman Biotech & Pharma Consulting, LLCFoundercurrent2019 — present
- NOETIKMember, Scientific Advisory Boardcurrent2025 — present
- Hexagon BioConsulting CMOcurrent2024 — present
- Coast-to-Coast BioConsultantsCo-Foundercurrent2024 — present
- OnckoStrategic Advisorcurrent2026 — present
- OnckoCo-Foundercurrent2024 — present
- Bolt Biotherapeutics, Inc.Member, Development Advisory Boardcurrent2025 — present
- Designing Dreams USAMember Board of Directorscurrent2025 — present
- Ginkgo Bioworks, Inc.Advisory Board Member2024 — 2026
- Day One Biopharmaceuticals (Acquired by Servier)Member Board of Directors2024 — 2026
- Gilead SciencesSVP - Oncology Clinical Development, Therapeutic Area Head2021 — 2024Foster City, California, United States
- BryoLogyxOncology Advisory Board2021 — 2024
- BryoLogyxMember Board Of Directors2019 — 2021California
- Tizona Therapeutics, Inc.Member Board Of Directors2021 — 2023
- Pionyr ImmunotherapeuticsMember Board Of Directors2021 — 2023
- Arcus BiosciencesChief Medical Officer2019 — 2021Hayward, California
- Bellicum Pharmaceuticals, Inc.SVP, Chief Medical Officer2018 — 2019South San Francisco
- GenentechGroup Medical Director, Cancer Immunotherapy - Global Product Development Oncology2015 — 2018
- AbbVieTherapeutic Area Lead, Oncology - Global Pharmaceutical R&D/Global Medical Affairs2013 — 2015North Chicago
- BiotheraSenior Vice President, Research & Development2011 — 2013
Skills & more
Hematology56Immunology95Oncology99Clinical5Transplantation3Pediatrics3Clinical Development36Infectious Diseases10Clinical Research70Life Sciences16Cancer19Biotechnology22
+9 more
Clinical TrialsDiagnosticsResearchScienceMolecular BiologyHealthcareR&DTranslational MedicineMedicineFrom Bill's professional profile.
Frequently asked questions
- Who is Bill Grossman?
- Co-founder, Strategic Advisor at Oncko
- Where does Bill Grossman work?
- Bill Grossman is Co-founder, Strategic Advisor of Oncko.
- What companies did Bill Grossman found?
- Bill Grossman founded Oncko.
- Where did Bill Grossman go to school?
- Bill Grossman studied at Washington University School of Medicine in St. Louis (MD, PhD); St. Louis Children's Hospital (Fellowship - Hematology/Oncology/Transplantation); St. Louis Children's Hospital (Internship/Residency).
Same school
Also attended Washington University School of Medicine in St. Louis17
Reid HuberPartner at Third Rock VenturesDavid CohnInterim Chief Executive Officer and Chief Medical Officer at Oncology VenturesGlenn PierceScientific Advisory Group Co-Chair at Pathway to CuresBen ScruggsPartner at Hatteras Venture PartnersDaguang WangManaging Director at Yonjin Venture LLCDave VreelandSenior Managing Partner at Caduceus Capital Partners
+ 11 more
Also attended University of St. Thomas31
Kayla HinderscheidHead of Network Development at Menlo VenturesRyan KruizengaGeneral Partner at Arthur VenturesDerek BuschowEntrepreneur in Residence at Arthur VenturesKyle FrederickDirector at Arthur VenturesChloe GinkelAssociate at Arthur VenturesMegan BanieckeAssociate at Homegrown Capital
.png)
+ 25 more
